pharmaceuticals for the treatment of neurodegenerative conditions and diseases, neuroinflammatory diseases, cardiovascular diseases, pulmonary diseases, cancer and oncological diseases, and diseases of aging; pharmaceuticals that reduce or modulate inflammation in disease